BTB Therapeutics, Inc.

CIK 2055053 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for BTB Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 12, 2026D/A0002055053-26-000003
Dec 1, 2025D0002055053-25-000003
Feb 5, 2025D0002055053-25-000001
Feb 5, 2025D0002055053-25-000001